| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.140 | None | 1.000 | 23 | 11 | 2007 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.110 | None | 1.000 | 8 | 10 | 2007 | 2017 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.110 | None | 1.000 | 5 | 8 | 2007 | 2015 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.110 | None | 1.000 | 2 | 4 | 2019 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
group | 0.100 | None | 1.000 | 18 | 7 | 2007 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
phenotype | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 18 | 6 | 2007 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 14 | 16 | 2007 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 9 | 17 | 2007 | 2014 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2018 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 1 | 7 | 2010 | 2010 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2017 | 2017 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
group | 0.030 | None | 1.000 | 3 | 8 | 2017 | 2018 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.030 | None | 1.000 | 3 | 4 | 2015 | 2017 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
group | 0.030 | None | 1.000 | 3 | 8 | 2017 | 2018 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.010 | None | 1.000 | 1 | 3 | 2016 | 2016 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.010 | None | 1.000 | 1 | 3 | 2016 | 2016 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 |